Goldman Sachs
CLBT icon

Goldman Sachs’s Cellebrite CLBT Stock Holding History

Goldman Sachs’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
266,066
+1,148
+0.4% +$17.3K ﹤0.01% 3994
2025
Q4 		$4.78M Buy
264,918
+67,280
+34% +$1.21M ﹤0.01% 3787
2025
Q3 		$3.66M Sell
197,638
-144,003
-42% -$2.26M ﹤0.01% 3934
2025
Q2 		$5.47M Buy
341,641
+228,695
+202% +$4.08M ﹤0.01% 3326
2025
Q1 		$2.19M Sell
112,946
-149,240
-57% -$3.14M ﹤0.01% 4082
2024
Q4 		$5.78M Sell
262,186
-125,964
-32% -$2.42M ﹤0.01% 3310
2024
Q3 		$6.54M Sell
388,150
-957,661
-71% -$14.2M ﹤0.01% 3113
2024
Q2 		$16.1M Buy
1,345,811
+810,221
+151% +$9.05M ﹤0.01% 2058
2024
Q1 		$5.93M Buy
535,590
+239,816
+81% +$2.45M ﹤0.01% 2940
2023
Q4 		$2.56M Buy
295,774
+199,107
+206% +$1.55M ﹤0.01% 3733
2023
Q3 		$740K Buy
96,667
+77,508
+405% +$582K ﹤0.01% 4446
2023
Q2 		$138K Sell
19,159
-111,516
-85% -$650K ﹤0.01% 5294
2023
Q1 		$796K Buy
130,675
+96,133
+278% +$521K ﹤0.01% 4548
2022
Q4 		$151K Sell
34,542
-16,196
-32% -$72.3K ﹤0.01% 5388
2022
Q3 		$199K Buy
50,738
+26,407
+109% +$132K ﹤0.01% 5485
2022
Q2 		$124K Buy
24,331
+563
+2% +$2.93K ﹤0.01% 5802
2022
Q1 		$152K Buy
23,768
+1,717
+8% +$11.4K ﹤0.01% 5978
2021
Q4 		$177K Buy
+22,051
New +$208K ﹤0.01% 5947

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs's CLBT Position: Q1 2026 in Review

Goldman Sachs increased its Cellebrite (CLBT) stake by 0.43% in Q1 2026, buying an estimated $17.3K and bringing the position to 266,066 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

Goldman Sachs first reported a position in CLBT in Q4 2021 and has held it in 18 quarters since. The position peaked at $16.1M in Q2 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Goldman Sachs held 266,066 shares of Cellebrite worth $3.67M as of Q1 2026.
  • Goldman Sachs bought 1,148 Cellebrite shares in Q1 2026, an estimated $17.3K.
  • Cellebrite made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3994 holding.
  • Goldman Sachs first reported a position in Cellebrite in Q4 2021 and has held it in 18 quarters since.
  • Goldman Sachs's Cellebrite position peaked at $16.1M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.